BASHAN DROR (President & CEO) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2024ACC: 0001415889-24-010099
DirectorOfficer· President & CEO
Since Jun 2019
+263.96K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
263.96K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+263.96K
Price / share
—
Trade value
—
% of position
14.0%
4/1/2024
1.89M→2.15M
Total
Net shares
+263.96K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/1/2024 | A · Award | +263.96K | — | — | 14.0% | 1.89M | 2.15M |
| Total | +263.96K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned132.52K
Total
132.52K direct132.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 132.52K | Direct |
| Total | 132.52K | 132.52K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported